Merck · 9 hours ago
2026 Future Talent Program – In Vitro Neuroimmunology – Co-op
Boston, MA
Full-time
Onsite
New Grad
$40K/yr - $106K/yrMerck is a leading global healthcare company, and they are seeking a motivated student for their Future Talent Program in In Vitro Neuroimmunology. This co-op position will involve contributing to in vitro experiments and collaborating with colleagues in the Early Discovery Neuroscience team to support CNS drug discovery.
BiotechnologyHealth CareMedicalPharmaceutical
No H1B
Responsibilities
Design, execute, interpret and report in vitro experiments
Assist in developing, executing, and troubleshooting new cell assays, protocols and cell imaging methods
Support characterization and validation of compound/biologic agent activity in cell-based assays
Communication of data clearly and concisely to teams and stakeholders
Monitor, review and critically interpret published work to guide their own research
Collaborate with members from other functional areas, including medicinal chemistry, and in vitro pharmacology and genetics
Qualification
Required
Candidate must be actively working towards a BS/BA degree in Biological Sciences or a related discipline such as chemistry, pharmacy or health related fields
Candidate must have a strong desire to develop knowledge of neuroscience drug discovery
Preferred
Candidate should have some experience with basic lab procedures: pipetting, solution preparation, and plate assays
Candidate should have some experience with basic mammalian cell culture, i.e., transfections, primary microglia
Candidate should have demonstrated ability to perform accurate data analysis
Candidate should have excellent oral and written communication skills, including preparation of lab reports and presentations and strong attention to detail
Candidate should demonstrate interest in conducting experiments to determine efficacy of test compounds, establish dose-response and pharmacokinetic/pharmacodynamic relationships
Company
Merck
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Founded in 1891
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$5.59MKey Investors
Private Capital AdvisorsGavi, the Vaccine Alliance
2018-11-25Post Ipo Equity· $0.59M
2016-01-21Series Unknown· $5M
1980-12-19IPO
Leadership Team
Betty Larson
Executive Vice President and Chief Human Resources Officer
Dean Li
Executive Vice President and President, Merck Research Laboratories
Recent News
2026-01-23
2026-01-23
Company data provided by crunchbase